APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Therapeutics Pharmaceutical Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Analysis and Forecast 2026-2032

2 May 2026228 pages

Choose your research edition.

Industry ResearchAdvanced Therapeutics Pharmaceutical Outsourcing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Therapeutics Pharmaceutical Outsourcing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Therapeutics Pharmaceutical Outsourcing Market Analysis and Forecast 2026-2032228 pages · $4,950 USD

Market perspective

The global Advanced Therapeutics Pharmaceutical Outsourcing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Advanced Therapeutics Pharmaceutical Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Advanced Therapeutics Pharmaceutical Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Advanced Therapeutics Pharmaceutical Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Advanced Therapeutics Pharmaceutical Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Advanced Therapeutics Pharmaceutical Outsourcing include Croda International Plc, Charles River Laboratories International, Inc., Catalent, Inc., QuintileslMS (IQVIA), Parexel International Corporation, ICON plc, PPD, Inc. (Thermo Fisher Scientific), LabCorp (Laboratory Corporation of America Holdings) and Syneos Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Advanced Therapeutics Pharmaceutical Outsourcing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Advanced Therapeutics Pharmaceutical Outsourcing, also provides the revenue of main regions and countries. Of the upcoming market potential for Advanced Therapeutics Pharmaceutical Outsourcing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Advanced Therapeutics Pharmaceutical Outsourcing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Advanced Therapeutics Pharmaceutical Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Advanced Therapeutics Pharmaceutical Outsourcing revenue, projected growth trends, production technology, application and end-user industry.

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Company

Croda International Plc

Charles River Laboratories International, Inc.

Catalent, Inc.

QuintileslMS (IQVIA)

Parexel International Corporation

ICON plc

PPD, Inc. (Thermo Fisher Scientific)

LabCorp (Laboratory Corporation of America Holdings)

Syneos Health

wuXi AppTecLonza Group

Piramal Pharma Solutions

SGS SA

Evotec SE

CMC Biologics (Now AGC Biologics)

Marken (A UPS Company)

Cytovance Biologics

Samsung Biologics

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Type

Contract Research Organizations (CROs)

Contract Development and Manufacturing Organizations (CDMOs)

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Application

Preclinical Services

Clinical Services

Commercial Manufacturing and Packaging

Advanced Therapeutics Pharmaceutical Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapeutics Pharmaceutical Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapeutics Pharmaceutical Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapeutics Pharmaceutical Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Advanced Therapeutics Pharmaceutical Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Advanced Therapeutics Pharmaceutical Outsourcing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Therapeutics Pharmaceutical Outsourcing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Contract Research Organizations (CROs) Major Player Table 3. Contract Development and Manufacturing Organizations (CDMOs) Major Player Table 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Preclinical Services Major Player Table 6. Clinical Services Major Player Table 7. Commercial Manufacturing and Packaging Major Player Table 8. Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends Table 9. Advanced Therapeutics Pharmaceutical Outsourcing Industry Drivers Table 10. Advanced Therapeutics Pharmaceutical Outsourcing Industry Opportunities and Challenges Table 11. Advanced Therapeutics Pharmaceutical Outsourcing Industry Restraints Table 12. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Share by Region (2021-2026) Table 15. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Share by Region (2027-2032) Table 17. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Players (2021-2026) Table 19. Global Advanced Therapeutics Pharmaceutical Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Advanced Therapeutics Pharmaceutical Outsourcing Key Players Headquarters & Area Served Table 21. Global Advanced Therapeutics Pharmaceutical Outsourcing Players, Product Type & Application Table 22. Global Advanced Therapeutics Pharmaceutical Outsourcing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Advanced Therapeutics Pharmaceutical Outsourcing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Type (2021-2026) Table 29. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Type (2027-2032) Table 30. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Application (2021-2026) Table 34. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Application (2027-2032) Table 35. Croda International Plc Company Information Table 36. Croda International Plc Business Overview Table 37. Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 39. Croda International Plc Recent Development Table 40. Charles River Laboratories International, Inc. Company Information Table 41. Charles River Laboratories International, Inc. Business Overview Table 42. Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 44. Charles River Laboratories International, Inc. Recent Development Table 45. Catalent, Inc. Company Information Table 46. Catalent, Inc. Business Overview Table 47. Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 49. Catalent, Inc. Recent Development Table 50. QuintileslMS (IQVIA) Company Information Table 51. QuintileslMS (IQVIA) Business Overview Table 52. QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 54. QuintileslMS (IQVIA) Recent Development Table 55. Parexel International Corporation Company Information Table 56. Parexel International Corporation Business Overview Table 57. Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 59. Parexel International Corporation Recent Development Table 60. ICON plc Company Information Table 61. ICON plc Business Overview Table 62. ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 64. ICON plc Recent Development Table 65. PPD, Inc. (Thermo Fisher Scientific) Company Information Table 66. PPD, Inc. (Thermo Fisher Scientific) Business Overview Table 67. PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 69. PPD, Inc. (Thermo Fisher Scientific) Recent Development Table 70. LabCorp (Laboratory Corporation of America Holdings) Company Information Table 71. LabCorp (Laboratory Corporation of America Holdings) Business Overview Table 72. LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 74. LabCorp (Laboratory Corporation of America Holdings) Recent Development Table 75. Syneos Health Company Information Table 76. Syneos Health Business Overview Table 77. Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 79. Syneos Health Recent Development Table 80. wuXi AppTecLonza Group Company Information Table 81. wuXi AppTecLonza Group Business Overview Table 82. wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 84. wuXi AppTecLonza Group Recent Development Table 85. Piramal Pharma Solutions Company Information Table 86. Piramal Pharma Solutions Business Overview Table 87. Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 89. Piramal Pharma Solutions Recent Development Table 90. SGS SA Company Information Table 91. SGS SA Business Overview Table 92. SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 94. SGS SA Recent Development Table 95. Evotec SE Company Information Table 96. Evotec SE Business Overview Table 97. Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 99. Evotec SE Recent Development Table 100. CMC Biologics (Now AGC Biologics) Company Information Table 101. CMC Biologics (Now AGC Biologics) Business Overview Table 102. CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 104. CMC Biologics (Now AGC Biologics) Recent Development Table 105. Marken (A UPS Company) Company Information Table 106. Marken (A UPS Company) Business Overview Table 107. Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 109. Marken (A UPS Company) Recent Development Table 110. Cytovance Biologics Company Information Table 111. Cytovance Biologics Business Overview Table 112. Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 114. Cytovance Biologics Recent Development Table 115. Samsung Biologics Company Information Table 116. Samsung Biologics Business Overview Table 117. Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio Table 119. Samsung Biologics Recent Development Table 120. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 134. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 135. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 136. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 137. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Advanced Therapeutics Pharmaceutical Outsourcing Image Figure 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Contract Research Organizations (CROs) Image Figure 5. Contract Development and Manufacturing Organizations (CDMOs) Image Figure 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Preclinical Services Image Figure 9. Clinical Services Image Figure 10. Commercial Manufacturing and Packaging Image Figure 11. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size (US$ Million) & (2021-2032) Figure 12. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Advanced Therapeutics Pharmaceutical Outsourcing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Type (2021-2032) Figure 19. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Application (2021-2032) Figure 22. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032) Figure 24. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032) Figure 25. North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Country (2021-2032) Figure 26. United States Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032) Figure 31. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032) Figure 32. Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Country (2021-2032) Figure 33. Germany Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032) Figure 43. China Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032) Figure 44. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032) Figure 46. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032) Figure 47. Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Region (2021-2032) Figure 48. Japan Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032) Figure 56. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032) Figure 57. SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Country (2021-2032) Figure 58. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
Applications
  • Preclinical Services
  • Clinical Services
  • Commercial Manufacturing and Packaging
Companies covered
  • Croda International Plc
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • QuintileslMS (IQVIA)
  • Parexel International Corporation
  • ICON plc
  • PPD, Inc. (Thermo Fisher Scientific)
  • LabCorp (Laboratory Corporation of America Holdings)
  • Syneos Health
  • wuXi AppTecLonza Group
  • Piramal Pharma Solutions
  • SGS SA
  • Evotec SE
  • CMC Biologics (Now AGC Biologics)
  • Marken (A UPS Company)
  • Cytovance Biologics
  • Samsung Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Advanced Therapeutics Pharmaceutical Outsourcing Market by Type
  3. 1.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Contract Research Organizations (CROs)
  5. 1.2.3 Contract Development and Manufacturing Organizations (CDMOs)
  6. 1.3 Advanced Therapeutics Pharmaceutical Outsourcing Market by Application
  7. 1.3.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Preclinical Services
  9. 1.3.3 Clinical Services
  10. 1.3.4 Commercial Manufacturing and Packaging
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Advanced Therapeutics Pharmaceutical Outsourcing Market Dynamics
  1. 2.1 Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends
  2. 2.2 Advanced Therapeutics Pharmaceutical Outsourcing Industry Drivers
  3. 2.3 Advanced Therapeutics Pharmaceutical Outsourcing Industry Opportunities and Challenges
  4. 2.4 Advanced Therapeutics Pharmaceutical Outsourcing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Perspective (2021-2032)
  2. 3.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Growth Trends by Region
  3. 3.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2021-2026)
  5. 3.2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Players
  2. 4.1.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Players (2021-2026)
  3. 4.1.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Key Players Headquarters & Area Served
  7. 4.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Players, Product Type & Application
  8. 4.5 Global Advanced Therapeutics Pharmaceutical Outsourcing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market CR5 and HHI
  11. 4.6.3 2025 Advanced Therapeutics Pharmaceutical Outsourcing Tier 1, Tier 2, and Tier 3
5 Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Type
  1. 5.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 5.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Type (2021-2032)
6 Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Application
  1. 6.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  3. 6.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Croda International Plc
  2. 7.1.1 Croda International Plc Company Information
  3. 7.1.2 Croda International Plc Business Overview
  4. 7.1.3 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  6. 7.1.5 Croda International Plc Recent Developments
  7. 7.2 Charles River Laboratories International, Inc.
  8. 7.2.1 Charles River Laboratories International, Inc. Company Information
  9. 7.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 7.2.3 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  12. 7.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 7.3 Catalent, Inc.
  14. 7.3.1 Catalent, Inc. Company Information
  15. 7.3.2 Catalent, Inc. Business Overview
  16. 7.3.3 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  18. 7.3.5 Catalent, Inc. Recent Developments
  19. 7.4 QuintileslMS (IQVIA)
  20. 7.4.1 QuintileslMS (IQVIA) Company Information
  21. 7.4.2 QuintileslMS (IQVIA) Business Overview
  22. 7.4.3 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  24. 7.4.5 QuintileslMS (IQVIA) Recent Developments
  25. 7.5 Parexel International Corporation
  26. 7.5.1 Parexel International Corporation Company Information
  27. 7.5.2 Parexel International Corporation Business Overview
  28. 7.5.3 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  30. 7.5.5 Parexel International Corporation Recent Developments
  31. 7.6 ICON plc
  32. 7.6.1 ICON plc Company Information
  33. 7.6.2 ICON plc Business Overview
  34. 7.6.3 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  36. 7.6.5 ICON plc Recent Developments
  37. 7.7 PPD, Inc. (Thermo Fisher Scientific)
  38. 7.7.1 PPD, Inc. (Thermo Fisher Scientific) Company Information
  39. 7.7.2 PPD, Inc. (Thermo Fisher Scientific) Business Overview
  40. 7.7.3 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  42. 7.7.5 PPD, Inc. (Thermo Fisher Scientific) Recent Developments
  43. 7.8 LabCorp (Laboratory Corporation of America Holdings)
  44. 7.8.1 LabCorp (Laboratory Corporation of America Holdings) Company Information
  45. 7.8.2 LabCorp (Laboratory Corporation of America Holdings) Business Overview
  46. 7.8.3 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  48. 7.8.5 LabCorp (Laboratory Corporation of America Holdings) Recent Developments
  49. 7.9 Syneos Health
  50. 7.9.1 Syneos Health Company Information
  51. 7.9.2 Syneos Health Business Overview
  52. 7.9.3 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  54. 7.9.5 Syneos Health Recent Developments
  55. 7.10 wuXi AppTecLonza Group
  56. 7.10.1 wuXi AppTecLonza Group Company Information
  57. 7.10.2 wuXi AppTecLonza Group Business Overview
  58. 7.10.3 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  60. 7.10.5 wuXi AppTecLonza Group Recent Developments
  61. 7.11 Piramal Pharma Solutions
  62. 7.11.1 Piramal Pharma Solutions Company Information
  63. 7.11.2 Piramal Pharma Solutions Business Overview
  64. 7.11.3 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  66. 7.11.5 Piramal Pharma Solutions Recent Developments
  67. 7.12 SGS SA
  68. 7.12.1 SGS SA Company Information
  69. 7.12.2 SGS SA Business Overview
  70. 7.12.3 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  72. 7.12.5 SGS SA Recent Developments
  73. 7.13 Evotec SE
  74. 7.13.1 Evotec SE Company Information
  75. 7.13.2 Evotec SE Business Overview
  76. 7.13.3 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  78. 7.13.5 Evotec SE Recent Developments
  79. 7.14 CMC Biologics (Now AGC Biologics)
  80. 7.14.1 CMC Biologics (Now AGC Biologics) Company Information
  81. 7.14.2 CMC Biologics (Now AGC Biologics) Business Overview
  82. 7.14.3 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  84. 7.14.5 CMC Biologics (Now AGC Biologics) Recent Developments
  85. 7.15 Marken (A UPS Company)
  86. 7.15.1 Marken (A UPS Company) Company Information
  87. 7.15.2 Marken (A UPS Company) Business Overview
  88. 7.15.3 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  90. 7.15.5 Marken (A UPS Company) Recent Developments
  91. 7.16 Cytovance Biologics
  92. 7.16.1 Cytovance Biologics Company Information
  93. 7.16.2 Cytovance Biologics Business Overview
  94. 7.16.3 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  96. 7.16.5 Cytovance Biologics Recent Developments
  97. 7.17 Samsung Biologics
  98. 7.17.1 Samsung Biologics Company Information
  99. 7.17.2 Samsung Biologics Business Overview
  100. 7.17.3 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
  102. 7.17.5 Samsung Biologics Recent Developments
8 North America
  1. 8.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2032)
  2. 8.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 8.2.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026)
  4. 8.2.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032)
  5. 8.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032)
  6. 8.4 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  7. 8.4.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026)
  8. 8.4.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032)
  9. 8.5 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032)
  10. 8.6 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country
  11. 8.6.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026)
  13. 8.6.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2032)
  2. 9.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032)
  5. 9.3 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032)
  9. 9.5 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country
  11. 9.6.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2032)
  2. 10.2 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 10.2.1 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026)
  4. 10.2.2 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032)
  5. 10.3 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032)
  6. 10.4 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  7. 10.4.1 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026)
  8. 10.4.2 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032)
  9. 10.5 China Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2032)
  2. 11.2 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032)
  5. 11.3 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032)
  9. 11.5 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country
  11. 11.6.1 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2032)
  2. 12.2 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country
  11. 12.6.1 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Advanced Therapeutics Pharmaceutical Outsourcing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst